PALIPalisade Bio, Inc.

PALI Stock Price, Valuation & Chart | Palisade Bio, Inc.

Compare

$1.990+0.03 (+1.53%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology PALI intrinsic value PALI calculated fair value vs price

Overview Financials Dividends Ratios

PALI Historical price chart

PALI Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization345.42M

PE Ratio-1.9

EPS-1.05

Trading Volume730.43K

Today's High/Low2.0/1.95

Dividend Yield0.00

52 Week High/Low2.86/0.53

Shares Outstanding173.58M

PALI Financial Statement

PALI Analyst ratings

PALI Analysis & performance metrics

PALI Company profile

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated…

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit…

PALI Management team

Name

Position

Joerg Heyer Ph.D.

Head of Translational Science & Medicine

J. D. FinleyCEO

Chief Executive Officer, Chief Financial Officer & Director

Mitchell Lawrence Jones M.D., Ph.D.COO

Chief Operating Officer & Chief Medical Officer

Ryker Willie

Senior Vice President of Finance & Corporate Controller

Name

Position

Joerg Heyer Ph.D.

Head of Translational Science & Medicine

J. D. FinleyCEO

Chief Executive Officer, Chief Financial Officer & Director

Mitchell Lawrence Jones M.D., Ph.D.COO

Chief Operating Officer & Chief Medical Officer

Ryker Willie

Senior Vice President of Finance & Corporate Controller

Management Team

Joerg Heyer Ph.D.

Head of Translational Science & Medicine

J. D. FinleyCEO

Chief Executive Officer, Chief Financial Officer & Director

Mitchell Lawrence Jones M.D., Ph.D.COO

Chief Operating Officer & Chief Medical Officer

Ryker Willie

Senior Vice President of Finance & Corporate Controller

Management

Joerg Heyer Ph.D.

Head of Translational Science & Medicine

J. D. FinleyCEO

Chief Executive Officer, Chief Financial Officer & Director

Mitchell Lawrence Jones M.D., Ph.D.COO

Chief Operating Officer & Chief Medical Officer

Ryker Willie

Senior Vice President of Finance & Corporate Controller

Total 4 executives

PALI Frequently asked questions

What is Palisade Bio, Inc. (PALI) Stock Price?

Current stock price of Palisade Bio, Inc. (PALI) stock is $1.990. The stock price is +1.53% higher in the session. The intraday range can be seen from this page. Volume of Palisade Bio, Inc. (PALI) stock is 730.43K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Palisade Bio, Inc. (PALI) stock price going up or down today?

The stock price of Palisade Bio, Inc. (PALI) can change with earnings, company news, and overall market sentiment. Palisade Bio, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Palisade Bio, Inc. stock expensive at its current price?

Whether Palisade Bio, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PALI on this page is -1.90. EPS on this page is -1.05. Compare those figures with peers and growth expectations before deciding if the current Palisade Bio, Inc. price is justified.

How has the stock price of Palisade Bio, Inc. (PALI) performed historically?

Historical performance for Palisade Bio, Inc. (PALI) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PALI reacted to past earnings and market events.

Should I buy Palisade Bio, Inc. (PALI) stock, at this price?

Buying Palisade Bio, Inc. (PALI) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.